These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3508491)

  • 1. Antigenic changes in gp70 associated with the adult variant of Gross murine leukemia virus, WB91.
    Jones SM; Spear BT; Klyczek KK; Pozsgay JM; Gaudet E; Yao D; Blank KJ
    Microb Pathog; 1986 Jun; 1(3):275-82. PubMed ID: 3508491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific infection of central nervous system white matter by a variant of gross murine leukemia virus.
    Simonian NA; Rosenthal LA; Korostoff J; Hickey WF; Blank KJ; Gaulton GN
    Virology; 1990 Jul; 177(1):384-7. PubMed ID: 2353463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo generation of antigenic variants of murine retroviruses.
    Pozsgay JM; Klyczek KK; Blank KJ
    Virology; 1989 Nov; 173(1):330-4. PubMed ID: 2479171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo.
    Plata F; Langlade-Demoyen P; Abastado JP; Berbar T; Kourilsky P
    Cell; 1987 Jan; 48(2):231-40. PubMed ID: 3026637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endogenous mink cell focus-forming (MCF) gp70 linked to the Rmcf gene restricts MCF virus replication in vivo and provides partial resistance to erythroleukemia induced by Friend murine leukemia virus.
    Buller RS; Sitbon M; Portis JL
    J Exp Med; 1988 May; 167(5):1535-46. PubMed ID: 2835418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCF-specific murine monoclonal antibodies made against AKR-247 MCF virus recognize a unique determinant associated with the gp70-p-15(E) complex.
    Cloyd MW; Chesebro B; Portis JL; Weir M
    J Virol; 1982 Mar; 41(3):1112-7. PubMed ID: 6178839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of gp70-specific suppressor T-cells in mice inoculated with virus-producing tumor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1982 Oct; 69(4):953-9. PubMed ID: 6214655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
    Cloyd MW; Evans LH
    J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.
    Poss ML; Mullins JI; Hoover EA
    J Virol; 1989 Jan; 63(1):189-95. PubMed ID: 2535725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of retrovirus associated antigens (p30 and gp70) on cell membranes of feline and murine leukaemia virus infected cells.
    O'Brien SJ; Simonson JM; Davis S
    J Gen Virol; 1978 Mar; 38(3):483-96. PubMed ID: 75945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of proximal and distal sequence variations in the presentation of an immunodominant CTL epitope encoded by the ecotropic AK7 MuLV.
    Kim V; Green WR
    Virology; 1997 Sep; 236(2):221-33. PubMed ID: 9325230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral proteins expressed on the surface of murine leukemia cells.
    Ledbetter J; Nowinski RC; Emery S
    J Virol; 1977 Apr; 22(1):65-73. PubMed ID: 67223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.